Reviving the antibiotic pipeline: an industrial perspective on scientific, economic, and policy challenge

The global antibiotic development pipeline is critically declining due to interconnected scientific, economic, regulatory, manufacturing, and policy challenges, worsening the antimicrobial resistance (AMR) crisis. The review examines the antibiotic pipeline from an industrial viewpoint, highlighting significant scientific, economic, and regulatory challenges. It proposes policy reforms and incentive models to encourage sustainable innovation and ensure equitable access to new antibiotics. Bacterial AMR was responsible for approximately 1.27 million deaths and associated with nearly 4.95 million deaths globally in 2019, notably in western sub-Saharan Africa. In the U.S., the CDC cites around 2.8 million resistant infections and over 35,000 deaths annually. Projections suggest that without action, AMR could lead to 10 million deaths per year by 2050 and result in multi-trillion USD economic losses. The review synthesizes findings from extensive literature across databases like PubMed and ScienceDirect, focusing on articles from January 2010 to June 2025, with an emphasis on high-quality evidence. The data underscore the urgent need for a comprehensive, multi-stakeholder strategy incorporating novel discovery platforms, push–pull economic incentives, adaptive regulatory pathways, and regionalized manufacturing models. Strengthening global partnerships between policymakers, funders, and industry is essential to rejuvenate the antibiotic pipeline, safeguard therapeutic effectiveness, and ensure equitable global access.

Authors

Institutions

Publication Details

Journal
Future Microbiology
Published
2026-11-14
DOI
https://doi.org/10.1080/17460913.2026.2757709
Primary Topic
Antibiotic Use and Resistance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Reviving the antibiotic pipeline: an industrial perspective on scientific, economic, and policy challenge

Melvin George, Murali Krishna Moka, Deepalaxmi Rathakrishnan, Sriram D. K.
Future Microbiology
Antibiotic Use and Resistance
article

Reviving the antibiotic pipeline: an industrial perspective on scientific, economic, and policy challenge

Melvin George, Murali Krishna Moka, Deepalaxmi Rathakrishnan, Sriram D. K.
article en

Abstract

The global antibiotic development pipeline is critically declining due to interconnected scientific, economic, regulatory, manufacturing, and policy challenges, worsening the antimicrobial resistance (AMR) crisis. The review examines the antibiotic pipeline from an industrial viewpoint, highlighting significant scientific, economic, and regulatory challenges. It proposes policy reforms and incentive models to encourage sustainable innovation and ensure equitable access to new antibiotics. Bacterial AMR was responsible for approximately 1.27 million deaths and associated with nearly 4.95 million deaths globally in 2019, notably in western sub-Saharan Africa. In the U.S., the CDC cites around 2.8 million resistant infections and over 35,000 deaths annually. Projections suggest that without action, AMR could lead to 10 million deaths per year by 2050 and result in multi-trillion USD economic losses. The review synthesizes findings from extensive literature across databases like PubMed and ScienceDirect, focusing on articles from January 2010 to June 2025, with an emphasis on high-quality evidence. The data underscore the urgent need for a comprehensive, multi-stakeholder strategy incorporating novel discovery platforms, push–pull economic incentives, adaptive regulatory pathways, and regionalized manufacturing models. Strengthening global partnerships between policymakers, funders, and industry is essential to rejuvenate the antibiotic pipeline, safeguard therapeutic effectiveness, and ensure equitable global access.

Future Microbiology
Hindu Mission Hospital (IN)
Antibiotic Use and Resistance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon